| Cat. No. |
Product Name |
Information |
| PC-21329 |
GSK023
BET BD1 inhibitor
|
GSK023 is a potent, selective BET BD1 domain inhibitor with pIC50 of 7.8 against BRD4 BD1, >100-fold selective over BD2. |
| PC-21303 |
CN210
BET bromodomain inhibitor
|
CN210 is a quinazoline-based BET family inhibitor with Kd value of 70 nM for BRD4 (BD1,2) and IC50 of 0.94 uM in MV4-11 viability assay. |
| PC-21267 |
Dual PI3K/BET 18DS
PI3K/BET inhibitor
|
Dual PI3K/BET 18DS is a potent, chimeric dual PI3K/BET bromodomain inhibitor, demonstrates high selectivity, nanomolar range cellular potency, and compelling in vivo efficacy. |
| PC-21167 |
GNE-234
|
GNE-234 is the negative control compound of the selective PBRM1(2) inhibitor GNE-235. |
| PC-21166 |
GNE-235
PBRM1(2) inhibitor
|
GNE-235 (GNE235) is a potent, selective inhibitor of the second bromodomain of polybromo-1 (PBRM1; BAF180; PB1) with KD value of 0.28 uM in BROMOscan assays. |
| PC-21073 |
IV-275
BRG1/BRM inhibitor
|
IV-275 is a next-generation inhibitor of BRG1 and BRM bromodomains, inhibits SWI/SNF complex and enhances DNA damage and cell death in glioblastoma. |
| PC-21072 |
IV-255
BRG1 selective inhibitor
|
IV-255 is a next-generation selective inhibitor of BRG1 bromodomain, inhibits SWI/SNF complex and enhances DNA damage and cell death in glioblastoma. |
| PC-20948 |
DDO-8926
BET inhibitor
|
DDO-8926 is a potent selective inhibitor of bromodomain and extra-terminal (BET) proteins with Ki values of 15 nM (BRD4 BD1) and 9.5 nM (BRD4 BD2). |
| PC-72758 |
BPTF inhibitor BZ1
BPTF inhibitor
|
BPTF inhibitor BZ1 is a potent, selective, cell-active inhibitor of bromodomain PHD finger transcription factor (BPTF) with Kd of 6.3 nM, >350-fold selectivity over BET bromodomains. |
| PC-35016 |
IBET151-Az
|
IBET151-Az is a IBET151 derivative for PROTAC synthesis.. |
| PC-43339 |
(R)-(-)-JQ1 Enantiomer
|
(R)-(-)-JQ1 Enantiomer is the stereoisomer of (+)-JQ1, (+)-JQ-1 is a potent, specific BET bromodomain BRD4 inhibitor, but (-)-JQ1 has no activity.. |
